Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000151784 | SCV000200236 | likely benign | not specified | 2014-07-14 | criteria provided, single submitter | clinical testing | Ser1137Ser in exon 19 of SCN5A: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue and is not located wi thin the splice consensus sequence. |
Labcorp Genetics |
RCV001582622 | SCV000291801 | likely benign | not provided | 2023-12-06 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001842468 | SCV001352078 | likely benign | Cardiac arrhythmia | 2019-02-16 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001582622 | SCV001812286 | likely benign | not provided | 2019-01-30 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV001842468 | SCV004827424 | likely benign | Cardiac arrhythmia | 2023-12-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004668809 | SCV005159775 | likely benign | Cardiovascular phenotype | 2024-03-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Clinical Genetics, |
RCV000151784 | SCV001917179 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001582622 | SCV001966540 | likely benign | not provided | no assertion criteria provided | clinical testing |